共 50 条
- [1] Deep remission in Crohn's disease does not prevent disease relapse after withdrawal of anti-TNFa therapy [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S4 - S4
- [2] Meta-Analysis: Retreatment of Inflammatory Bowel Disease Patients Who Previously Achieved Deep Remission With Anti-TNFa and Subsequently Stopped Therapy Electively [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1593 - S1593
- [3] Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (10): : 1413 - 1423
- [5] Lympocytosis in patients with inflammatory bowel disease treated with anti-TNFa agents: is it significant? [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S322 - S322
- [6] Risk of relapse after anti-TNF discontinuation in Inflammatory Bowel Disease: A meta-analysis [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S315 - S315
- [8] Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (01): : 85 - 85
- [9] Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn’s Disease: A Meta-Analysis [J]. Digestive Diseases and Sciences, 2011, 56 : 1929 - 1936